Assessment for effect and safety of Tenofovir Disoproxil Fumarate Tablets in the treatment of hepatitis B: a randomized, double blinding by double simulation, positive agent, multicenter trial

Trial Profile

Assessment for effect and safety of Tenofovir Disoproxil Fumarate Tablets in the treatment of hepatitis B: a randomized, double blinding by double simulation, positive agent, multicenter trial

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned end date (Nov 2012) added as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned initiation date changed from 1 Mar 2010 to 1 Mar 2012 as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top